logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
08/08/2025
Ding Pharmaceutical fell by 10% again. The company's net loss in the first half of 2025 was 89.165 million US dollars, a year-on-year decrease of 33.33%.
Latest
now
Medical technology company Heartflow (HTFL.US) prices its IPO above expectations, raising $317 million. It will debut on Nasdaq tonight.
1 m ago
China Electric Power Construction Corporation establishes a new energy technology company, including construction engineering design business.
2 m ago
On the 7th local time, the 39% tariff rate imposed by the United States on imported goods from Switzerland officially took effect. In Geneva, many Swiss people expressed concerns about this high tariff policy, saying that it would greatly restrict Swiss exports to the United States, leading to a slowdown in the country's economic growth and an increase in unemployment. Although Swiss Federal President Keller-Sutter stated at a press conference on the 7th that the Swiss Federal Council will continue to work with the United States to improve its export environment to the United States, concerns about the impact of high tariffs among many local people in Geneva have been expressed. (CCTV News)
3 m ago
Stock market anomaly | Wynn Macau (01128.HK) dropped over 7%, with the controlling shareholder reporting a 9.51% year-on-year decline in adjusted EBITDAR for the second quarter in Macau.
3 m ago
Goldman Sachs released a research report stating that the second quarter revenue of SMIC increased by 16% year-on-year, surpassing the bank and market expectations by 4% and 2% respectively. The gross profit margin recorded 20.4%, slightly higher than the company's guidance and market expectations, mainly due to the increase in production capacity utilization to 92.5% compared to less than 90% in the first quarter. The group's revenue guidance for the third quarter is expected to grow by 5% to 7% quarterly, in line with market expectations, while the gross profit margin is expected to be maintained at 18% to 20%, slightly lower than Goldman Sachs' expected 20.6% and the market expectation of 21.1%. Looking forward, the potential for domestic demand in China to drive long-term growth, Goldman Sachs maintains a "buy" rating on SMIC with a target price of HK$63.7, believing that despite pricing competition and depreciation pressures, the improvement in production capacity utilization and the mass production of 12-inch factories are expected to gradually boost the gross profit margin.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.